Dr. Goyal is an Assistant Professor in the Division of Hematology-Oncology at University of Alabama at Birmingham (UAB). During his fellowship training at Mayo Clinic, he developed a unique focus in a rare group of blood diseases called as histiocytic neoplasms, including Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease. He has conducted multiple studies describing the epidemiology, treatments, and outcomes of patients with histiocytosis and led to the establishment of the first of its kind multidisciplinary Histiocytosis Working Group. He has led national and international guidelines on the diagnosis and management of these rare disease entities. He continues to conduct clinical, translational and outcomes research in histiocytosis at his current position. He has developed special interest in survivorship research with ongoing projects evaluating burden of morbidity and mortality among individuals with histiocytic disorders.